ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,702,739, issued on Aug. 11.
"Device and method for administering an anti cancer substance" was invented by Brian J Leberthon (Arcadia, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "An anti-cancer substance is administered via the patient's blood ex vivo and in line by establishing a connection between the patient and a device having a chamber containing the anti-cancer substance. The patient's blood in the chamber and the anti-cancer substance interact so that immune cells in the blood (1) are activated to produce an immune response in the patient, or (2) are pre-armed by attaching to the cells antibodies, or (3) both. After activating or pre-ar...